Tumor-specific PI3K inhibition via nanoparticle targeted delivery in head and neck squamous cell carcinoma

被引：0
|
作者：
Mizrachi, Aviram
Shamay, Yosi
Shah, Janki
Brook, Samuel I.
Soong, Joanne
Rajasekhar, Vinagolu K.
Humm, John L.
Powell, Simon N.
Baselga, Jose
Heller, Daniel A.
Haimovitz-Friedman, Adriana
Scaltriti, Maurizio
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4122
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4122
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Identification of NOTCH1 inactivating mutation as a therapeutic vulnerability to PI3K/mTOR pathway inhibition in head and neck squamous cell carcinoma (HNSCC)
    Sambandam, Vaishnavi
    Shen, Li
    Tong, Pan
    Mazumdar, Tuhina
    Pickering, Curtis
    Myers, Jeffrey N.
    Wang, Jing
    Frederick, Mitchell
    Johnson, Faye M.
    CANCER RESEARCH, 2017, 77
  • [42] HRAS G12V predicts for innate resistance to PI3Kα inhibition in head and neck squamous cell cancer
    Ruicci, Kara M.
    Sun, Ren
    Black, Morgan
    Pinto, Nicole
    Yoo, John
    Fung, Kevin
    Macneil, Danielle
    Aillies, Lauire
    Mymryk, Joseph S.
    Boutros, Paul C.
    Barrett, John W.
    Nichols, Anthony C.
    CANCER RESEARCH, 2017, 77
  • [43] Osthole induces cell cycle arrest and apoptosis in head and neck squamous cell carcinoma by suppressing the PI3K/AKT signaling pathway
    Yang, Jing
    Zhu, Xin-jiang
    Jin, Ming-zhu
    Cao, Zhi-wei
    Ren, Yao-yao
    Gu, Zhao-wei
    CHEMICO-BIOLOGICAL INTERACTIONS, 2020, 316
  • [44] Head and neck squamous cell carcinoma targeted chemosensitization
    Figures, Mindy R.
    Wobb, Jessie
    Araki, Koji
    Liu, Tingyan
    Xu, Lei
    Zhu, Hanjing
    O'Malley, Bert W., Jr.
    Li, Daqing
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2009, 141 (02) : 177 - 183
  • [45] Targeted Therapies in Squamous Cell Carcinoma of the Head and Neck
    Gold, Kathryn A.
    Lee, Ho-Young
    Kim, Edward S.
    CANCER, 2009, 115 (05) : 922 - 935
  • [46] Inhibition of PI3K Isoform p110γ Increases Both Anti-Tumor and Immunosuppressive Responses to Aggressive Murine Head and Neck Squamous Cell Carcinoma with Low Immunogenicity
    Anderson, Kelvin
    Ryan, Nathan
    Alkhimovitch, Anastasia
    Siddiqui, Arham
    Oghumu, Steve
    CANCERS, 2021, 13 (05) : 1 - 17
  • [47] PI3K pathway mutation predicts an activated immune microenvironment and better immunotherapeutic efficacy in head and neck squamous cell carcinoma
    Wang, Libo
    Chen, Kejun
    Weng, Siyuan
    Xu, Hui
    Ren, Yuqing
    Cheng, Quan
    Luo, Peng
    Zhang, Jian
    Liu, Zaoqu
    Han, Xinwei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [48] PI3K pathway mutation predicts an activated immune microenvironment and better immunotherapeutic efficacy in head and neck squamous cell carcinoma
    Libo Wang
    Kejun Chen
    Siyuan Weng
    Hui Xu
    Yuqing Ren
    Quan Cheng
    Peng Luo
    Jian Zhang
    Zaoqu Liu
    Xinwei Han
    World Journal of Surgical Oncology, 21
  • [49] NOTCH1 inactivating mutation mediates sensitivity to PI3K/mTOR inhibitors in head and neck squamous cell carcinoma
    Johnson, Faye M.
    Sambandam, Vaishnavi
    Shen, Li
    Zhang, Ming
    Saigal, Rishi
    Tong, Pan
    Mazumdar, Tuhina
    Byers, Lauren A.
    Pickering, Curtis
    Myers, Jeffrey N.
    Wang, Jing
    Frederick, Mitchell
    CANCER RESEARCH, 2016, 76
  • [50] Dual PI3K/mTOR blockade by NVP-BEZ235 sensitizes head and neck squamous cell carcinoma to radiotherapy
    Gao, Ming
    Wang, Chun-Wei
    Fang, Chun Sheng
    Lu, Yen-Shen
    Cheng, Ann-Lii
    CANCER RESEARCH, 2012, 72
12345